Congress urged to pass Opioid Workforce Act

Dec 05, 2019 - 03:16 PM
opioids

The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Related News Articles

Headline
Webinar to discuss how leaders strengthen clinical workforce
The AHA will host a webinar March 19 at 1 p.m. ET that will explore how leaders are improving retention, physician well-being and coverage…
Perspective
Hospitals Face Increased Costs of Caring for Patients
Public
A hospital patient from the 1990s would likely marvel at the pace of progress in health care just a generation later. America’s hospitals and health systems…
Headline
AHA podcast: Better Teams, Better Mental Health Care 
Jeremy Fish, M.D., director of the Family Medicine Residency Program at John Muir Health, and Pilar Corcoran-Lozano, behavioral health corps faculty and…
Headline
SAMHSA announces mental health, suicide prevention grants 
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
HHS, DOE announce nutrition education initiative for medical schools
The Departments of Health and Human Services and Education March 5 announced a new initiative to increase nutrition education in medical schools beginning this…
Headline
FDA issues RFI on in-home opioid disposal products
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…